Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide.

Rancourt RC, Veress LA, Guo X, Jones TN, Hendry-Hofer TB, White CW.

Am J Physiol Lung Cell Mol Physiol. 2012 Jan 1;302(1):L82-92. doi: 10.1152/ajplung.00306.2010. Epub 2011 Sep 30.

2.

Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy.

White CW, Rancourt RC, Veress LA.

Ann N Y Acad Sci. 2016 Aug;1378(1):87-95. doi: 10.1111/nyas.13130. Epub 2016 Jul 6. Review.

3.

Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo.

Tewari-Singh N, Agarwal C, Huang J, Day BJ, White CW, Agarwal R.

J Pharmacol Exp Ther. 2011 Feb;336(2):450-9. doi: 10.1124/jpet.110.173708. Epub 2010 Oct 25. Review.

4.

The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.

Hoffman M, Monroe DM 3rd.

Dis Mon. 2003 Jan;49(1):14-21. Review.

PMID:
12525825
5.

Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review.

Ghanei M, Harandi AA.

Inhal Toxicol. 2011 Jun;23(7):363-71. doi: 10.3109/08958378.2011.576278. Review.

6.

Emerging targets for treating sulfur mustard-induced injuries.

Ahmad S, Ahmad A.

Ann N Y Acad Sci. 2016 Jun;1374(1):123-31. doi: 10.1111/nyas.13095. Epub 2016 Jun 10. Review.

7.

Tissue factor initiated blood coagulation.

Gomez K, McVey JH.

Front Biosci. 2006 May 1;11:1349-59. Review.

PMID:
16368521
8.

[Expression of thrombogenic substances by neoplasms: TF and cancer procoagulant. Pathogenic effects].

UszyƄski M.

Ginekol Pol. 2000 Oct;71(10):1287-92. Review. Polish.

PMID:
11143939

Supplemental Content

Support Center